Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Pre-Sterilized Nested Vials Market Poised To Hit $2.36 Billion By 2030 With A 13.7% CAGR
The pre-sterilized nested vials market size has experienced rapid expansion in recent years. This market is projected to grow from $1.24 billion in 2025 to $1.41 billion in 2026, achieving a compound annual growth rate (CAGR) of 13.5%. Historically, this expansion has been driven by factors such as an escalating demand for injectable medications, the widespread adoption of pre-sterilized vials, the proliferation of biologics and vaccines, an uptick in contract manufacturing activities, and rigorous pharmaceutical packaging regulations.
The pre-sterilized nested vials market is projected to experience substantial expansion over the upcoming period. This market is anticipated to reach $2.36 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 13.7%. Key drivers for this growth throughout the forecast timeframe include increased automation in aseptic fill-finish processes, the emergence of environmentally friendly nested vials, a rise in vaccine manufacturing capabilities, the uptake of sophisticated polymer and glass materials, and the incorporation of digital tracking and monitoring solutions. Significant trends identified for the projected period encompass the integration of automated aseptic filling, wider acceptance of pre-sterilized packaging, automation in nested vial handling, advancements in material science, and efforts to optimize regulatory compliance.
Get A Free Sample Report With In-Depth Market Insights:
Pre-Sterilized Nested Vials Market Growth Drivers: What’s Behind The Acceleration?
The increased acceptance of biologics is projected to boost the expansion of the pre-sterilized nested vials market. This adoption signifies the growing utilization of biologic treatments by medical professionals and individuals in standard clinical settings. The impetus behind this lies in biologics’ capacity to provide precise therapeutic outcomes, especially for chronic, autoimmune, and metabolic conditions, areas where traditional small-molecule drugs frequently exhibit reduced effectiveness. Pre-sterilized nested vials facilitate the expanding application of biologics by supplying ready-to-use, contamination-free primary packaging options, thereby guaranteeing product safety, maintaining drug stability, and minimizing preparation time during aseptic filling and administration processes. As an illustration, the Generics and Biosimilars Initiative (GaBI), a Belgium-based organization disseminating scientific data on generic and biosimilar pharmaceuticals, stated in October 2024 that in addition to the nine primary biologics, two other intricate biologic medications—Novo Nordisk’s Ozempic (semaglutide) and Eli Lilly’s Trulicity (dulaglutide), both prescribed for type 2 diabetes—achieved substantial sales in 2023, amounting to roughly US$14 billion and US$7.2 billion, respectively. Consequently, the increased uptake of biologics is propelling the expansion of the pre-sterilized nested vials market.
Pre-Sterilized Nested Vials Market Breakdown By Product Type And Application
The pre-sterilized nested vials market covered in this report is segmented –
1) By Product Type: Glass Nested Vials, Plastic Nested Vials
2) By Sterilization Method: Gamma Sterilization, Ethylene Oxide Sterilization, Steam Sterilization, Other Sterilization Methods
3) By Capacity: 2R, 6R, 10R, 20R, Other Capacities
4) By Application: Injectable Drugs Packaging, Biologics Packaging, Vaccine Packaging, Clinical Trial Packaging, Aseptic Fill-Finish Operations
5) By End-User: Hospitals, Contract Manufacturing Organizations, Research Institutes, Other End-Users
Subsegments:
1) By Glass Nested Vials: Type I Borosilicate, Type II Soda Lime Treated, Type III Soda Lime, Neutral Glass
2) By Plastic Nested Vials: Polypropylene, Polyethylene, Cyclo Olefin Polymer, Polycarbonate
Pre-Sterilized Nested Vials Market Trends: What’s Defining The Industry’s Next Phase?
Major companies operating in the pre-sterilized nested vials market are concentrating on developing innovative solutions, such as container closure integrity, to ensure sterile drug delivery, prevent contamination, and maintain the stability and safety of pharmaceutical products. Container closure integrity refers to a packaging system’s ability to uphold a complete seal that effectively prevents contamination, leakage, or loss of sterility. For instance, in May 2024, West Pharmaceutical Services Inc., a US-based manufacturing company, launched Daikyo Crystal Zenith (CZ) Nested Vials in a Tub. These are ready-to-use, pre-sterilized cyclic olefin polymer (COP) vials designed for sensitive therapies like cell/gene treatments and radiopharmaceuticals. Available in 2 mL (100 vials/tub) and 10 mL (48 vials/tub) sizes, with external dimensions resembling ISO 8362-1 glass, they ensure cryogenic container closure integrity, low particulates (<2% USP <788>), high viral vector recovery, breakage resistance, and minimal chemical interactions.
Pre-Sterilized Nested Vials Market Top Companies Driving Competitive Growth
Major companies operating in the pre-sterilized nested vials market are Corning Incorporated, Terumo Corporation, Nipro PharmaPackaging, West Pharmaceutical Services Inc., Gerresheimer AG, Datwyler Holding Inc., Stevanato Group, SCHOTT AG, Shandong Pharmaceutical Glass Co. Ltd., SGD Pharma, Bormioli Pharma, Adelphi Healthcare Packaging, DWK Life Sciences, Linuo Glassworks Group, SiO2 Materials Science, Jinan Youlyy Industrial Co. Ltd., Origin Pharma Packaging, Pacific Vial Manufacturing Inc., Daikyo Seiko Ltd., Qorpak, AptarGroup Inc., QCVIALZ LLC.
View The Full Pre-Sterilized Nested Vials Market Report:
Pre-Sterilized Nested Vials Market Global Footprint: Which Region Leads The Industry?
North America was the largest region in the pre-sterilized nested vials market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pre-sterilized nested vials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
